Cerevel Therapeutics Hldng I shares owned by Morgan Stanley
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $14M | 331k | 40.89 |
| 2024-03-31 | $22M | 514k | 42.27 |
| 2023-12-31 | $32M | 756k | 42.40 |
| 2023-09-30 | $1.8M | 84k | 21.83 |
| 2023-06-30 | $5.1M | 161k | 31.79 |
| 2022-12-31 | $17M | 552k | 31.55 |
| 2022-06-30 | $10M | 385k | 26.18 |
| 2022-03-31 | $3.7M | 106k | 35.01 |
| 2021-06-30 | $0 | 16k | 0.00 |
| 2020-12-31 | $238k | 14k | 16.56 |